Tomita N, Ishiyama H, Makita C, Ohshima Y, et al. Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial. BMC Cancer 2022;22:1259.
PMID: 36471274